1. Home
  2. ELWT vs ALDX Comparison

ELWT vs ALDX Comparison

Compare ELWT & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elauwit Connection Inc.

ELWT

Elauwit Connection Inc.

N/A

Current Price

$5.35

Market Cap

47.5M

ML Signal

N/A

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

N/A

Current Price

$0.63

Market Cap

39.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELWT
ALDX
Founded
2002
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
39.2M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
ELWT
ALDX
Price
$5.35
$0.63
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $6.60
AVG Volume (30 Days)
12.7K
★ 1.8M
Earning Date
11-15-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
18.37
★ 40.43
EPS
N/A
★ N/A
Revenue
★ $21,618,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$111.37
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 154.48
N/A
52 Week Low
$4.11
$0.60
52 Week High
$9.72
$5.93

Technical Indicators

Market Signals
Indicator
ELWT
ALDX
Relative Strength Index (RSI) 33.55 26.66
Support Level $5.30 N/A
Resistance Level $7.99 $1.58
Average True Range (ATR) 0.40 0.07
MACD 0.01 -0.00
Stochastic Oscillator 39.36 9.82

Price Performance

Historical Comparison
ELWT
ALDX

About ELWT Elauwit Connection Inc.

Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: